Annual FCF
-$40.90 M
-$5.93 M-16.94%
December 31, 2023
Summary
- As of February 7, 2025, HEPA annual free cash flow is -$40.90 million, with the most recent change of -$5.93 million (-16.94%) on December 31, 2023.
- During the last 3 years, HEPA annual FCF has fallen by -$24.65 million (-151.66%).
- HEPA annual FCF is now -2866.36% below its all-time high of -$1.38 million, reached on June 30, 2014.
Performance
HEPA Free Cash Flow Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly FCF
-$2.52 M
+$8.41 M+76.96%
September 30, 2024
Summary
- As of February 7, 2025, HEPA quarterly free cash flow is -$2.52 million, with the most recent change of +$8.41 million (+76.96%) on September 30, 2024.
- Over the past year, HEPA quarterly FCF has increased by +$8.72 million (+77.59%).
- HEPA quarterly FCF is now -2174.53% below its all-time high of -$110.70 thousand, reached on September 30, 2013.
Performance
HEPA Quarterly FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM FCF
-$26.07 M
+$8.72 M+25.06%
September 30, 2024
Summary
- As of February 7, 2025, HEPA TTM free cash flow is -$26.07 million, with the most recent change of +$8.72 million (+25.06%) on September 30, 2024.
- Over the past year, HEPA TTM FCF has increased by +$10.63 million (+28.97%).
- HEPA TTM FCF is now -23446.07% below its all-time high of -$110.70 thousand, reached on September 30, 2013.
Performance
HEPA TTM FCF Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Free Cash Flow Formula
FCF = Cash From Operations − CAPEX
HEPA Free Cash Flow Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | -16.9% | +77.6% | +29.0% |
| 3 y3 years | -151.7% | +65.9% | +16.9% |
| 5 y5 years | -161.4% | +65.9% | +16.9% |
HEPA Free Cash Flow Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -30.4% | at low | at high | +79.9% | at high | +36.3% |
| 5 y | 5-year | -437.0% | at low | -2.9% | +79.9% | -242.2% | +36.3% |
| alltime | all time | -2866.4% | at low | -2174.5% | +79.9% | <-9999.0% | +36.3% |
Hepion Pharmaceuticals Free Cash Flow History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$2.52 M(-77.0%) | -$26.07 M(-25.1%) |
| Jun 2024 | - | -$10.93 M(+202.2%) | -$34.78 M(-4.2%) |
| Mar 2024 | - | -$3.62 M(-59.8%) | -$36.31 M(-11.2%) |
| Dec 2023 | -$40.90 M(+16.9%) | -$9.00 M(-19.9%) | -$40.90 M(+11.5%) |
| Sep 2023 | - | -$11.23 M(-9.8%) | -$36.70 M(-3.4%) |
| Jun 2023 | - | -$12.45 M(+51.6%) | -$38.00 M(+15.0%) |
| Mar 2023 | - | -$8.21 M(+71.2%) | -$33.05 M(-5.5%) |
| Dec 2022 | -$34.98 M(+11.6%) | -$4.80 M(-61.7%) | -$34.96 M(-6.9%) |
| Sep 2022 | - | -$12.53 M(+67.1%) | -$37.55 M(+3.2%) |
| Jun 2022 | - | -$7.50 M(-26.0%) | -$36.37 M(+6.8%) |
| Mar 2022 | - | -$10.13 M(+37.2%) | -$34.05 M(+8.6%) |
| Dec 2021 | -$31.35 M(+92.9%) | -$7.38 M(-35.0%) | -$31.36 M(+9.7%) |
| Sep 2021 | - | -$11.36 M(+119.2%) | -$28.57 M(+35.6%) |
| Jun 2021 | - | -$5.18 M(-30.3%) | -$21.07 M(+10.8%) |
| Mar 2021 | - | -$7.43 M(+61.5%) | -$19.01 M(+16.9%) |
| Dec 2020 | -$16.25 M(+113.4%) | -$4.60 M(+19.5%) | -$16.25 M(+15.3%) |
| Sep 2020 | - | -$3.85 M(+23.3%) | -$14.10 M(+17.0%) |
| Jun 2020 | - | -$3.12 M(-33.2%) | -$12.05 M(+18.2%) |
| Mar 2020 | - | -$4.68 M(+91.2%) | -$10.20 M(+33.9%) |
| Dec 2019 | -$7.62 M | -$2.45 M(+35.7%) | -$7.62 M(-25.8%) |
| Sep 2019 | - | -$1.80 M(+41.8%) | -$10.26 M(-14.5%) |
| Jun 2019 | - | -$1.27 M(-39.4%) | -$12.00 M(-15.2%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2019 | - | -$2.10 M(-58.8%) | -$14.15 M(-9.6%) |
| Dec 2018 | -$15.65 M(+90.6%) | -$5.09 M(+43.7%) | -$15.65 M(+48.3%) |
| Sep 2018 | - | -$3.54 M(+3.7%) | -$10.55 M(-14.8%) |
| Jun 2018 | - | -$3.42 M(-4.9%) | -$12.38 M(-6.3%) |
| Mar 2018 | - | -$3.59 M(-33.1%) | -$13.22 M(-34.5%) |
| Dec 2017 | -$8.21 M(-57.2%) | - | - |
| Sep 2017 | - | -$5.37 M(+26.4%) | -$20.18 M(+5.2%) |
| Jun 2017 | -$19.19 M(+15.9%) | -$4.25 M(-18.3%) | -$19.19 M(-0.7%) |
| Mar 2017 | - | -$5.20 M(-2.8%) | -$19.33 M(+7.4%) |
| Dec 2016 | - | -$5.35 M(+22.3%) | -$18.00 M(-0.7%) |
| Sep 2016 | - | -$4.38 M(-0.4%) | -$18.13 M(+9.5%) |
| Jun 2016 | -$16.56 M(+69.8%) | -$4.40 M(+13.4%) | -$16.56 M(+0.3%) |
| Mar 2016 | - | -$3.88 M(-29.3%) | -$16.51 M(+6.4%) |
| Dec 2015 | - | -$5.48 M(+95.5%) | -$15.52 M(+35.2%) |
| Sep 2015 | - | -$2.81 M(-35.4%) | -$11.48 M(+17.7%) |
| Jun 2015 | -$9.76 M(+607.5%) | -$4.34 M(+50.1%) | -$9.76 M(+59.7%) |
| Mar 2015 | - | -$2.89 M(+100.2%) | -$6.11 M(+71.0%) |
| Dec 2014 | - | -$1.44 M(+33.4%) | -$3.57 M(+52.0%) |
| Sep 2014 | - | -$1.08 M(+56.3%) | -$2.35 M(+70.5%) |
| Jun 2014 | -$1.38 M | -$692.40 K(+96.1%) | -$1.38 M(+100.9%) |
| Mar 2014 | - | -$353.00 K(+58.5%) | -$686.40 K(+105.9%) |
| Dec 2013 | - | -$222.70 K(+101.2%) | -$333.40 K(+201.2%) |
| Sep 2013 | - | -$110.70 K | -$110.70 K |
FAQ
- What is Hepion Pharmaceuticals annual free cash flow?
- What is the all time high annual FCF for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals annual FCF year-on-year change?
- What is Hepion Pharmaceuticals quarterly free cash flow?
- What is the all time high quarterly FCF for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals quarterly FCF year-on-year change?
- What is Hepion Pharmaceuticals TTM free cash flow?
- What is the all time high TTM FCF for Hepion Pharmaceuticals?
- What is Hepion Pharmaceuticals TTM FCF year-on-year change?
What is Hepion Pharmaceuticals annual free cash flow?
The current annual FCF of HEPA is -$40.90 M
What is the all time high annual FCF for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high annual free cash flow is -$1.38 M
What is Hepion Pharmaceuticals annual FCF year-on-year change?
Over the past year, HEPA annual free cash flow has changed by -$5.93 M (-16.94%)
What is Hepion Pharmaceuticals quarterly free cash flow?
The current quarterly FCF of HEPA is -$2.52 M
What is the all time high quarterly FCF for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high quarterly free cash flow is -$110.70 K
What is Hepion Pharmaceuticals quarterly FCF year-on-year change?
Over the past year, HEPA quarterly free cash flow has changed by +$8.72 M (+77.59%)
What is Hepion Pharmaceuticals TTM free cash flow?
The current TTM FCF of HEPA is -$26.07 M
What is the all time high TTM FCF for Hepion Pharmaceuticals?
Hepion Pharmaceuticals all-time high TTM free cash flow is -$110.70 K
What is Hepion Pharmaceuticals TTM FCF year-on-year change?
Over the past year, HEPA TTM free cash flow has changed by +$10.63 M (+28.97%)